Zurich Insurance Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Zurich Insurance Group LTD

$11.4 Billion
Q3 2024

A detailed history of Zurich Insurance Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurich Insurance Group LTD holds 63,641 shares of REGN stock, worth $44.7 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

63,641

Previous 92,350 31.09%

Holding current value

$44.7 Million

Previous $97.1 Million 31.07%

% of portfolio

0.59%

Previous 0.86%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $29.4 Million - $34.5 Million	-28,709 Reduced 31.09%	63,641 $66.9 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $34.8 Million - $42.2 Million	39,382 Added 74.35%	92,350 $97.1 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $18.7 Million - $20.6 Million	20,736 Added 64.33%	52,968 $51 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $36.5 Million - $41.5 Million	-47,092 Reduced 59.37%	32,232 $28.3 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $54.9 Million - $67 Million	79,324 New	79,324 $65.3 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $3.89 Million - $5.34 Million	-14,187 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $127,979 - $149,006	468 Added 3.41%	14,187 $3.94 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $162,083 - $224,417	541 Added 4.11%	13,719 $4.29 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $5.81 Million - $6.87 Million	-15,620 Reduced 54.24%	13,178 $5.41 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.84 Million - $2.21 Million	5,471 Added 23.45%	28,798 $10.8 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $26,335 - $30,638	-75 Reduced 0.32%	23,327 $9.43 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $3.88 Million - $4.7 Million	13,625 Added 139.36%	23,402 $8.07 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $455,728 - $568,224	-1,443 Reduced 12.86%	9,777 $3.37 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $494,550 - $648,061	1,379 Added 14.01%	11,220 $4.22 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $4.25 Million - $4.96 Million	9,841	9,841 $4.4 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.

Account

Zurich Insurance Group LTD Regeneron Pharmaceuticals, Inc. Transaction History